# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-23-039242
**Filing Date:** 2023-2
**Character Count:** 196264
**Document Hash:** b291cfe373415eaa9dba89783afcab63
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-039242.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001752724-23-039242

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**PERIOD START**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663
- **IRS NUMBER:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 23665285

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares Biotechnology ETF (Series ID: S000004350)

| Class ID   | Class Name                | Ticker Symbol   |
|:---|:---|:---|
| C000012080 | iShares Biotechnology ETF | IBB             |

## Nport-Ex

Schedule of Investments (unaudited)

December 01, 2022

Ghana's Biotechnology ETF
(Percentages shown are based on last 4 years)

| Security | Ghana | Value | Security | Ghana | Value |
| --- | --- | --- | --- | --- | --- |
| Common Stocks |  |  | Biotechnology (continued) |  |  |
| Biotechnology - 78.5% |  |  | Organic Biotechnology, Inc.TM | 465,464 | $5,128,870 |
| In-Schedule of Investments | 350,000 | $3,963,000 | Collarna Biotechnology, Inc.TM | 465,464 | $5,128,870 |
| All-Schedule International, Inc.TM | 328,000 | $3,963,000 | Common Refineries plc, ASWTM | 465,464 | $5,128,870 |
| Wiley, Inc.TM | 500,000 | $3,963,000 | Common Pharmaceuticals, Inc.TM | (Percentages shown are based on last 4 years) |  |
| Alkali plc, ASWTM | 1,451,000 | $21,866,500 | Common Pharmaceuticals, Inc.TM | 361,424 | $6,014,870 |

1

2

(сигналовки) (пояснения)

December 31, 2022

| Показатель | тыс. руб. | тыс. руб. | Среднее耻ие | Среднее耻ие | Среднее耻ие |
| --- | --- | --- | --- | --- | --- |
| Регулярная организация, тыс. руб. | 1,000,000 | 10,000,000 | Взгляды (взгляды), тыс. руб. | 831,000 | 35,420,372 |
| Взгляды (общая, целебная, etc.) | 217,364 | 1,200,000 | Взгляды (взгляды), тыс. руб. | 827,000 | 5,000,000 |
| Регулярная организация, тыс. руб. | 858,000 | 3,100,000 | Взгляды (взгляды), тыс. руб. | 730,000 | 10,000,000 |
| Регулярная организация, тыс. руб. | 878,000 | 3,200,000 | Взгляды (взгляды), тыс. руб. | 720,000 | 10,000,000 |
| Регулярная организация, тыс. руб. | 208,000 | 1,200,000 | Взгляды (взгляды), тыс. руб. | 1,200,000 | 10,000,000 |
| Регулярная организация, тыс. руб. | 402,000 | 2,000,000 | Взгляды (взгляды), тыс. руб. | 1,200,000 | 10,000,000 |
| Регулярная организация, тыс. руб. | 1,000,000 | 10,000,000 | Взгляды (взгляды), тыс. руб. | 1,200,000 | 10,000,000 |

# Schedule of Investments

(unaudited) (continued)

Ghana's Biotechnology ETF
(Percentages shown are based on last 4 years)

December 31, 2022

| International, Inc. (1) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (1) | 1,000,000 | 1,000,000 |
| --- | --- | --- | --- | --- | --- |
| Global Biotechnology, Inc. (2) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (2) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (3) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (3) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (4) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (4) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (5) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (5) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (6) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (6) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (7) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (7) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (8) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (8) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (9) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (9) | 1,000,000 | 1,000,000 |
| Global Biotechnology, Inc. (10) | 1,000,000 | 1,000,000 | Global Biotechnology, Inc. (10) | 1,000,000 | 1,000,000 |

3

Schedule of Investments

(unaudited) (continued)

Gharro's Biotechnology ETF

December 31, 2022

| Contraction Financial Instruments Outstanding as of Period End |  |  |
| --- | --- | --- |
| Balance at December 31, 2022 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2021 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2020 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2019 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2018 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2017 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2016 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2015 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2014 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2013 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2012 | 1,000,000 | 1,000,000 |
| Balance at December 31, 2011 | 1,000,000 | 1,000,000 |

| Balance, net of | 2,000,000 | 2,000,000 |
| --- | --- | --- |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 |  |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 |  |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |
| Net of the year | 1,000,000 | 1,000,000 |

1

1

1

1

[{"box_2d": [0, 32, 476, 92], "label": "table", "caption": "

| Bank of America | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |
| Debtors' Compensation and other related | 1,000,000 | 10,000,000 | Cash and cash equivalents | 1,000,000 | 10,000,000 |
| Debtors' Compensation and other related | 1,000,000 | 10,000,000 | Cash and cash equivalents | 1,000,000 | 10,000,000 |
| Debtors' Compensation and other related | 1,000,000 | 10,000,000 | Cash and cash equivalents | 1,000,000 | 10,000,000 |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |
| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |
| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

| Debtors' Compensation and other related | 1,000,000 | 5,000,000 | Cash and cash equivalents | 1,000,000 | 5,000,000 |
| --- | --- | --- | --- | --- | --- |

<table><tr><

| Total Reimbursement of the Company | 1,000,000 | 1,000,000 | Region Incentive, Inc. | 507,000 | 4,000,000 |
| --- | --- | --- | --- | --- | --- |
| Total Reimbursement of the Company | 1,000,000 | 1,000,000 | Total Reimbursement of the Company | 1,000,000 | 4,000,000 |
| Total Reimbursement of the Company | 1,000,000 | 1,000,000 | Total Reimbursement of the Company | 1,000,000 | 4,000,000 |
| Total Reimbursement of the Company | 1,000,000 | 1,000,000 | Total Reimbursement of the Company | 1,000,000 | 4,000,000 |

| Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity |
| Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity | Productivity |

[{"box_2d": [0, 32, 477, 93], "label": "table", "caption": "

| For commercials and services | 4000,000 | 11,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |
| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

| For the above mentioned and the General Laborer (Chile) (C) | 1,000,000 | 10,000,000 | National Industries, Inc. (Chile) (C) | 1,000,000 | 10,000,000 |
| --- | --- | --- | --- | --- | --- |

<table><tr><td>For the above mentioned and the

| APRIL | Philadelphia, Pa. 19 | 774,650 | 4,358,152 | Employee Care | 435,144 | Capital Cost |
| --- | --- | --- | --- | --- | --- | --- |
| APRIL | Philadelphia, Pa. 19 | 320,000 | 4,983,614 | Sales & Marketing | 280,000 | 2,000,000 |
| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |
| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

| Total | Philadelphia, Pa. 19 | 1,121,000 | 1,121,000 | General & Engineering | 280,000 | 2,000,000 |
| --- | --- | --- | --- | --- | --- | --- |

|  | $ | 6,573,853,000 | $ | 124,500 | $ | 1,000 | $ | 6,573,781,726 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | $ | 124,475 | $ | 380,667 | $ | 843,364,466 | $ | 3,346,615 |
|  |  |  |  |  |  |  |  | $ |
| Deviation Principal Networked** |  |  |  |  |  |  |  |  |
| Liabilities |  |  |  |  |  |  |  |  |
| • Net assets | $ | 157,790 | $ | - | $ | - | $ | 157,790 |
| • An amount per share (current period) |  |  |  |  |  |  |  |  |
| • All in a period represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments in and from elements of securities. |  |  |  |  |  |  |  |  |
| • Deviation financial instruments are limited contracts. Fray-to-contracts are raised at the unrealized appreciation (depreciation) on the instrument. |  |  |  |  |  |  |  |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares Biotechnology ETF

- **b. EDGAR series identifier (if any):** S000004350

- **c. LEI of Series:** 549300S7IVD88MPK0066

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-03-31

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $9561474368.01

**Total Liabilities:** $814850313.27

**Net Assets:** $8746624054.74

**Cash Not Reported:** $235768.03

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012080 | 9.88%                | 6.03%                | -3.57%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $11655225.18             | $700769435.72                              |
| Month 2  | $46742248.00             | $455748356.14                              |
| Month 3  | $-280532619.52           | $-49207343.05                              |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                                           | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| MannKind Corp.                                 | MannKind Corp.                                        | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |   2139726 | NS      | $11276356.02  | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Bicycle Therapeutics plc                       | Bicycle Therapeutics plc                              | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |    178457 | NS      | $5282327.20   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Ionis Pharmaceuticals, Inc.                    | Ionis Pharmaceuticals, Inc.                           | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |   1170458 | NS      | $44208198.66  | 0.51%             |  |  |  | No            |                  1 | On Loan: —       |
| Molecular Templates, Inc.                      | Molecular Templates, Inc.                             | CUSIP: 608550109<br>LEI: 529900VZKP6N0B8U5F61 | Long             | EC               | CORP              | US        |     16382 | NS      | $5373.30      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.                      | United Therapeutics Corp.                             | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |    373883 | NS      | $103973123.47 | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                     | uniQure NV                                            | CUSIP: N/A<br>LEI: 724500RPCTZLFYJZ3S98       | Long             | EC               | CORP              | NL        |    342119 | NS      | $7755837.73   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Prometheus Biosciences, Inc.                   | Prometheus Biosciences, Inc.                          | CUSIP: 74349U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    259277 | NS      | $28520470.00  | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Meridian Bioscience, Inc.                      | Meridian Bioscience, Inc.                             | CUSIP: 589584101<br>LEI: 549300ELSRZEFFFRX195 | Long             | EC               | CORP              | US        |    361401 | NS      | $12002127.21  | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Tango Therapeutics, Inc.                       | Tango Therapeutics, Inc.                              | CUSIP: 87583X109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    377962 | NS      | $2740224.50   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Madrigal Pharmaceuticals, Inc.                 | Madrigal Pharmaceuticals, Inc.                        | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |    103876 | NS      | $30150009.00  | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| 4D Molecular Therapeutics, Inc.                | 4D Molecular Therapeutics, Inc.                       | CUSIP: 35104E100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    239959 | NS      | $5329489.39   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Ligand Pharmaceuticals, Inc.                   | Ligand Pharmaceuticals, Inc.                          | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |    133233 | NS      | $8899964.40   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Stoke Therapeutics, Inc.                       | Stoke Therapeutics, Inc.                              | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |    186045 | NS      | $1717195.35   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Generation Bio Co.                             | Generation Bio Co.                                    | CUSIP: 37148K100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    410346 | NS      | $1612659.78   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Omega Therapeutics, Inc.                       | Omega Therapeutics, Inc.                              | CUSIP: 68217N105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    151747 | NS      | $866475.37    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| BioMarin Pharmaceutical, Inc.                  | BioMarin Pharmaceutical, Inc.                         | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |   1525603 | NS      | $157884654.47 | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Invivyd, Inc.                                  | Invivyd, Inc.                                         | CUSIP: 00534A102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    303636 | NS      | $455454.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Syneos Health, Inc.                            | Syneos Health, Inc.                                   | CUSIP: 87166B102<br>LEI: 549300F1ZGKDS8P6GU13 | Long             | EC               | CORP              | US        |    857475 | NS      | $31452183.00  | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Kymera Therapeutics, Inc.                      | Kymera Therapeutics, Inc.                             | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    355457 | NS      | $8872206.72   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Merus NV                                       | Merus NV                                              | CUSIP: N/A<br>LEI: 549300W8GPUWU8QNU293       | Long             | EC               | CORP              | NL        |    338251 | NS      | $5232742.97   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| 89bio, Inc.                                    | 89bio, Inc.                                           | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    325848 | NS      | $4148045.04   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp.                                   | Waters Corp.                                          | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |    494966 | NS      | $169565452.28 | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals, Inc.                   | Amylyx Pharmaceuticals, Inc.                          | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    338277 | NS      | $12499335.15  | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Exscientia plc                                 | Exscientia plc                                        | CUSIP: 30223G102<br>LEI: 213800XOQHH5CV85AD30 | Long             | EC               | CORP              | GB        |    704223 | NS      | $3753508.59   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Intercept Pharmaceuticals, Inc.                | Intercept Pharmaceuticals, Inc.                       | CUSIP: 45845P108<br>LEI: 254900JMB8TX5P688V24 | Long             | EC               | CORP              | US        |    295904 | NS      | $3660332.48   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Medpace Holdings, Inc.                         | Medpace Holdings, Inc.                                | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |    198963 | NS      | $42261730.83  | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Repligen Corp.                                 | Repligen Corp.                                        | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |    432185 | NS      | $73173242.35  | 0.84%             |  |  |  | No            |                  1 | On Loan: —       |
| Neurocrine Biosciences, Inc.                   | Neurocrine Biosciences, Inc.                          | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    788056 | NS      | $94125408.64  | 1.08%             |  |  |  | No            |                  1 | On Loan: No      |
| MeiraGTx Holdings plc                          | MeiraGTx Holdings plc                                 | CUSIP: N/A<br>LEI: 54930007YV6NYIOGFZ57       | Long             | EC               | CORP              | KY        |    292059 | NS      | $1904224.68   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Absci Corp.                                    | Absci Corp.                                           | CUSIP: 00091E109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    470923 | NS      | $988938.30    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Insmed, Inc.                                   | Insmed, Inc.                                          | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |   1109552 | NS      | $22168848.96  | 0.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Dyne Therapeutics, Inc.                        | Dyne Therapeutics, Inc.                               | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    237283 | NS      | $2750109.97   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals, Inc.                   | Rhythm Pharmaceuticals, Inc.                          | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |    405347 | NS      | $11803704.64  | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Biogen, Inc.                                   | Biogen, Inc.                                          | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |   1188573 | NS      | $329139635.16 | 3.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Poseida Therapeutics, Inc.                     | Poseida Therapeutics, Inc.                            | CUSIP: 73730P108<br>LEI: 549300USKSDMNGMN8V04 | Long             | EC               | CORP              | US        |    463368 | NS      | $2455850.40   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Design Therapeutics, Inc.                      | Design Therapeutics, Inc.                             | CUSIP: 25056L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    265011 | NS      | $2719012.86   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Kura Oncology, Inc.                            | Kura Oncology, Inc.                                   | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |    540355 | NS      | $6705805.55   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Mettler-Toledo International, Inc.             | Mettler-Toledo International, Inc.                    | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |    183921 | NS      | $265848609.45 | 3.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Akoya Biosciences, Inc.                        | Akoya Biosciences, Inc.                               | CUSIP: 00974H104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    144686 | NS      | $1384645.02   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals, Inc.                   | Tarsus Pharmaceuticals, Inc.                          | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    142871 | NS      | $2094488.86   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc.        | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |    421037 | NS      | $91743962.30  | 1.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Nurix Therapeutics, Inc.                       | Nurix Therapeutics, Inc.                              | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    351531 | NS      | $3859810.38   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Pliant Therapeutics, Inc.                      | Pliant Therapeutics, Inc.                             | CUSIP: 729139105<br>LEI: 5493002Q5LITR7VHZH02 | Long             | EC               | CORP              | US        |    317714 | NS      | $6141411.62   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Caribou Biosciences, Inc.                      | Caribou Biosciences, Inc.                             | CUSIP: 142038108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    427378 | NS      | $2683933.84   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Phathom Pharmaceuticals, Inc.                  | Phathom Pharmaceuticals, Inc.                         | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    158666 | NS      | $1780232.52   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Century Therapeutics, Inc.                     | Century Therapeutics, Inc.                            | CUSIP: 15673T100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    195800 | NS      | $1004454.00   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Immuneering Corp.                              | Immuneering Corp., Class A                            | CUSIP: 45254E107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    156728 | NS      | $760130.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Kiniksa Pharmaceuticals Ltd.                   | Kiniksa Pharmaceuticals Ltd., Class A                 | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | BM        |    276228 | NS      | $4137895.44   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Editas Medicine, Inc.                          | Editas Medicine, Inc.                                 | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               | CORP              | US        |    570984 | NS      | $5064628.08   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Ironwood Pharmaceuticals, Inc.                 | Ironwood Pharmaceuticals, Inc.                        | CUSIP: 46333X108<br>LEI: 549300PC8MR6QHH6P296 | Long             | EC               | CORP              | US        |   1249075 | NS      | $15476039.25  | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| Mirati Therapeutics, Inc.                      | Mirati Therapeutics, Inc.                             | CUSIP: 60468T105<br>LEI: 529900GYRW59IDQV6N54 | Long             | EC               | CORP              | US        |    445659 | NS      | $20192809.29  | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| Seer, Inc.                                     | Seer, Inc.                                            | CUSIP: 81578P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    341949 | NS      | $1983304.20   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Allogene Therapeutics, Inc.                    | Allogene Therapeutics, Inc.                           | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    670072 | NS      | $4214752.88   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Eiger BioPharmaceuticals, Inc.                 | Eiger BioPharmaceuticals, Inc.                        | CUSIP: 28249U105<br>LEI: 549300GO4VMIHDKJNU46 | Long             | EC               | CORP              | US        |    327848 | NS      | $386860.64    | 0.00%             |  |  |  | No            |                  1 | On Loan: —       |
| Edgewise Therapeutics, Inc.                    | Edgewise Therapeutics, Inc.                           | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    336194 | NS      | $3005574.36   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Argenx SE                                      | Argenx SE                                             | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |    341234 | NS      | $129269676.22 | 1.48%             |  |  |  | No            |                  1 | On Loan: —       |
| SpringWorks Therapeutics, Inc.                 | SpringWorks Therapeutics, Inc.                        | CUSIP: 85205L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    369918 | NS      | $9621567.18   | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Genmab A/S                                     | Genmab A/S                                            | CUSIP: 372303206<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |   4085156 | NS      | $173128911.28 | 1.98%             |  |  |  | No            |                  1 | On Loan: —       |
| DBV Technologies SA                            | DBV Technologies SA                                   | CUSIP: 23306J101<br>LEI: 969500PVBQFWQKVDMD80 | Long             | EC               | CORP              | FR        |   1102151 | NS      | $1686291.03   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Recursion Pharmaceuticals, Inc.                | Recursion Pharmaceuticals, Inc., Class A              | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    920815 | NS      | $7099483.65   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Zai Lab Ltd.                                   | Zai Lab Ltd.                                          | CUSIP: 98887Q104<br>LEI: 549300P2UYQ9U5LY1T58 | Long             | EC               | CORP              | KY        |    599665 | NS      | $18409715.50  | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| REVOLUTION Medicines, Inc.                     | REVOLUTION Medicines, Inc.                            | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |    567941 | NS      | $13528354.62  | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Blueprint Medicines Corp.                      | Blueprint Medicines Corp.                             | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |    487859 | NS      | $21373102.79  | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| Atara Biotherapeutics, Inc.                    | Atara Biotherapeutics, Inc.                           | CUSIP: 046513107<br>LEI: 549300WBXUXZRE03MS38 | Long             | EC               | CORP              | US        |    764436 | NS      | $2507350.08   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| MacroGenics, Inc.                              | MacroGenics, Inc.                                     | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |    486790 | NS      | $3266360.90   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics, Inc.                             | 10X Genomics, Inc., Class A                           | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |    716484 | NS      | $26108676.96  | 0.30%             |  |  |  | No            |                  1 | On Loan: —       |
| Myriad Genetics, Inc.                          | Myriad Genetics, Inc.                                 | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |    650073 | NS      | $9432559.23   | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Intra-Cellular Therapies, Inc.                 | Intra-Cellular Therapies, Inc.                        | CUSIP: 46116X101<br>LEI: 5299002U2KGF193IJA20 | Long             | EC               | CORP              | US        |    731652 | NS      | $38719023.84  | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| FibroGen, Inc.                                 | FibroGen, Inc.                                        | CUSIP: 31572Q808<br>LEI: 549300Q914ULWWY95822 | Long             | EC               | CORP              | US        |    721917 | NS      | $11565110.34  | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Bio-Techne Corp.                               | Bio-Techne Corp.                                      | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |   1295412 | NS      | $107363746.56 | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences, Inc.                          | Kodiak Sciences, Inc.                                 | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |    412911 | NS      | $2956442.76   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                            | Nektar Therapeutics                                   | CUSIP: 640268108<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |   1540982 | NS      | $3482619.32   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Reata Pharmaceuticals, Inc.                    | Reata Pharmaceuticals, Inc., Class A                  | CUSIP: 75615P103<br>LEI: 5299005F094GH9QDDD80 | Long             | EC               | CORP              | US        |    233192 | NS      | $8858964.08   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Theravance Biopharma, Inc.                     | Theravance Biopharma, Inc.                            | CUSIP: N/A<br>LEI: 5493007VTSXP4Z6MIW52       | Long             | EC               | CORP              | KY        |    490404 | NS      | $5502332.88   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Bluebird Bio, Inc.                             | Bluebird Bio, Inc.                                    | CUSIP: 09609G100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    666526 | NS      | $4612359.92   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| ADC Therapeutics SA                            | ADC Therapeutics SA                                   | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | CH        |    379882 | NS      | $1458746.88   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| WaVe Life Sciences Ltd.                        | WaVe Life Sciences Ltd.                               | CUSIP: N/A<br>LEI: 54930070006GPKFYZ813       | Long             | EC               | CORP              | SG        |    553111 | NS      | $3871777.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Sage Therapeutics, Inc.                        | Sage Therapeutics, Inc.                               | CUSIP: 78667J108<br>LEI: 5493000JX4BJS9W6CN35 | Long             | EC               | CORP              | US        |    426411 | NS      | $16263315.54  | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Ideaya Biosciences, Inc.                       | Ideaya Biosciences, Inc.                              | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |    338513 | NS      | $6150781.21   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Contra A/S                                     | Contra A/S                                            | CUSIP: 532CNT011<br>LEI: N/A                  | Long             | EC               | CORP              | DK        |     46839 | NS      | $0.47         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Cytek Biosciences, Inc.                        | Cytek Biosciences, Inc.                               | CUSIP: 23285D109<br>LEI: 549300K2J28BOC6FBO89 | Long             | EC               | CORP              | US        |    708478 | NS      | $7233560.38   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Bruker Corp.                                   | Bruker Corp.                                          | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |    828000 | NS      | $56593800.00  | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Roivant Sciences Ltd.                          | Roivant Sciences Ltd.                                 | CUSIP: N/A<br>LEI: 549300DL466NY5J6U724       | Long             | EC               | CORP              | BM        |   2955384 | NS      | $23613518.16  | 0.27%             |  |  |  | No            |                  1 | On Loan: —       |
| Twist Bioscience Corp.                         | Twist Bioscience Corp.                                | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |    457503 | NS      | $10893146.43  | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Alpine Immune Sciences, Inc.                   | Alpine Immune Sciences, Inc.                          | CUSIP: 02083G100<br>LEI: 5493000845S6RLSDWJ40 | Long             | EC               | CORP              | US        |    219548 | NS      | $1613677.80   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Cytokinetics, Inc.                             | Cytokinetics, Inc.                                    | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |    743875 | NS      | $34084352.50  | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| Lineage Cell Therapeutics, Inc.                | Lineage Cell Therapeutics, Inc.                       | CUSIP: 53566P109<br>LEI: 5299002BI4W22SDF8R25 | Long             | EC               | CORP              | US        |   1387271 | NS      | $1623107.07   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Sutro Biopharma, Inc.                          | Sutro Biopharma, Inc.                                 | CUSIP: 869367102<br>LEI: 5493005U6P15VD25P851 | Long             | EC               | CORP              | US        |    417223 | NS      | $3371161.84   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings, Inc.           | Arcturus Therapeutics Holdings, Inc.                  | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    191454 | NS      | $3247059.84   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Illumina, Inc.                                 | Illumina, Inc.                                        | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |   1311530 | NS      | $265191366.00 | 3.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Exelixis, Inc.                                 | Exelixis, Inc.                                        | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |   2630274 | NS      | $42189594.96  | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Quanterix Corp.                                | Quanterix Corp.                                       | CUSIP: 74766Q101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    279301 | NS      | $3868318.85   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Prothena Corp. plc                             | Prothena Corp. plc                                    | CUSIP: N/A<br>LEI: 5299009ZXQ8NIIJ8OL30       | Long             | EC               | CORP              | IE        |    380422 | NS      | $22920425.50  | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Fate Therapeutics, Inc.                        | Fate Therapeutics, Inc.                               | CUSIP: 31189P102<br>LEI: 549300L14Q4UHOODLA90 | Long             | EC               | CORP              | US        |    762037 | NS      | $7688953.33   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Day One Biopharmaceuticals, Inc.               | Day One Biopharmaceuticals, Inc.                      | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    329933 | NS      | $7100158.16   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Galapagos NV                                   | Galapagos NV                                          | CUSIP: 36315X101<br>LEI: 549300QKJ78IY0IOV655 | Long             | EC               | CORP              | BE        |    407724 | NS      | $18094791.12  | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Replimune Group, Inc.                          | Replimune Group, Inc.                                 | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |    267695 | NS      | $7281304.00   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Coherus Biosciences, Inc.                      | Coherus Biosciences, Inc.                             | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    609220 | NS      | $4825022.40   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Centessa Pharmaceuticals plc                   | Centessa Pharmaceuticals plc                          | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | GB        |    288087 | NS      | $893069.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Novocure Ltd.                                  | Novocure Ltd.                                         | CUSIP: N/A<br>LEI: 213800YPP55UMHWA4826       | Long             | EC               | CORP              | JE        |    863004 | NS      | $63301343.40  | 0.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Fulgent Genetics, Inc.                         | Fulgent Genetics, Inc.                                | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               | CORP              | US        |    158280 | NS      | $4713578.40   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Castle Biosciences, Inc.                       | Castle Biosciences, Inc.                              | CUSIP: 14843C105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    205630 | NS      | $4840530.20   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Xenon Pharmaceuticals, Inc.                    | Xenon Pharmaceuticals, Inc.                           | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |    501603 | NS      | $19778206.29  | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| Enanta Pharmaceuticals, Inc.                   | Enanta Pharmaceuticals, Inc.                          | CUSIP: 29251M106<br>LEI: 529900SSN4DODDQSN594 | Long             | EC               | CORP              | US        |    161009 | NS      | $7490138.68   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics, Inc.                      | Amicus Therapeutics, Inc.                             | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |   2287072 | NS      | $27925149.12  | 0.32%             |  |  |  | No            |                  1 | On Loan: —       |
| Cullinan Oncology, Inc.                        | Cullinan Oncology, Inc.                               | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    247624 | NS      | $2612433.20   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                         | PTC Therapeutics, Inc.                                | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    596455 | NS      | $22766687.35  | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Ultragenyx Pharmaceutical, Inc.                | Ultragenyx Pharmaceutical, Inc.                       | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |    543327 | NS      | $25172339.91  | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| BELLUS Health, Inc.                            | BELLUS Health, Inc.                                   | CUSIP: 07987C204<br>LEI: 549300QZYQDSMOXCP667 | Long             | EC               | CORP              | CA        |    865264 | NS      | $7112470.08   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Seres Therapeutics, Inc.                       | Seres Therapeutics, Inc.                              | CUSIP: 81750R102<br>LEI: 549300GMXBE5NUWISF13 | Long             | EC               | CORP              | US        |    777006 | NS      | $4351233.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Abcam plc                                      | Abcam plc                                             | CUSIP: 000380204<br>LEI: 213800B9N83DSNT33F79 | Long             | EC               | CORP              | GB        |   1421387 | NS      | $22116781.72  | 0.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvalent, Inc.                                 | Nuvalent, Inc., Class A                               | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    356517 | NS      | $10617076.26  | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Codexis, Inc.                                  | Codexis, Inc.                                         | CUSIP: 192005106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    532761 | NS      | $2482666.26   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Ventyx Biosciences, Inc.                       | Ventyx Biosciences, Inc.                              | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    239774 | NS      | $7862189.46   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Natera, Inc.                                   | Natera, Inc.                                          | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    823946 | NS      | $33097910.82  | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| Kinnate Biopharma, Inc.                        | Kinnate Biopharma, Inc.                               | CUSIP: 49705R105<br>LEI: 549300YVIWV7HJ5WHI66 | Long             | EC               | CORP              | US        |    182800 | NS      | $1115080.00   | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx, Inc.                                   | CareDx, Inc.                                          | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |    437222 | NS      | $4988703.02   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| UroGen Pharma Ltd.                             | UroGen Pharma Ltd.                                    | CUSIP: N/A<br>LEI: 549300C0YCX7CG2G5D50       | Long             | EC               | CORP              | IL        |    159509 | NS      | $1414844.83   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| ATAI Life Sciences NV                          | ATAI Life Sciences NV                                 | CUSIP: N/A<br>LEI: 391200Z8UWPJSNBNCA11       | Long             | EC               | CORP              | NL        |   1021424 | NS      | $2716987.84   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Mirum Pharmaceuticals, Inc.                    | Mirum Pharmaceuticals, Inc.                           | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |    190340 | NS      | $3711630.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| OPKO Health, Inc.                              | OPKO Health, Inc.                                     | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |   3458168 | NS      | $4322710.00   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| CinCor Pharma, Inc.                            | CinCor Pharma, Inc.                                   | CUSIP: 17240Y109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    145891 | NS      | $1793000.39   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Olink Holding AB                               | Olink Holding AB                                      | CUSIP: 680710100<br>LEI: 8945004Z7ZHV3LML4J27 | Long             | EC               | CORP              | SE        |    222322 | NS      | $5642532.36   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Pacific Biosciences of California, Inc.        | Pacific Biosciences of California, Inc.               | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |   1716551 | NS      | $14041387.18  | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Inhibrx, Inc.                                  | Inhibrx, Inc.                                         | CUSIP: 45720L107<br>LEI: 549300VBKG2LTV1TLY22 | Long             | EC               | CORP              | US        |    236754 | NS      | $5833618.56   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| MaxCyte, Inc.                                  | MaxCyte, Inc.                                         | CUSIP: 57777K106<br>LEI: 54930053YHXULRFCU991 | Long             | EC               | CORP              | US        |    727240 | NS      | $3970730.40   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| DICE Therapeutics, Inc.                        | DICE Therapeutics, Inc.                               | CUSIP: 23345J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    317143 | NS      | $9894861.60   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor, Inc.                                   | Xencor, Inc.                                          | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |    490702 | NS      | $12777880.08  | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Sarepta Therapeutics, Inc.                     | Sarepta Therapeutics, Inc.                            | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |    690562 | NS      | $89483023.96  | 1.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcutis Biotherapeutics, Inc.                  | Arcutis Biotherapeutics, Inc.                         | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    351137 | NS      | $5196827.60   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Allovir, Inc.                                  | Allovir, Inc.                                         | CUSIP: 019818103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    305416 | NS      | $1566784.08   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Deciphera Pharmaceuticals, Inc.                | Deciphera Pharmaceuticals, Inc.                       | CUSIP: 24344T101<br>LEI: 529900QR4WAPYY0CBF25 | Long             | EC               | CORP              | US        |    397529 | NS      | $6515500.31   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Summit Therapeutics, Inc.                      | Summit Therapeutics, Inc.                             | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    225892 | NS      | $960041.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Nuvation Bio, Inc.                             | Nuvation Bio, Inc., Class A                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1183958 | NS      | $2273199.36   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals, Inc.                     | Atea Pharmaceuticals, Inc.                            | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    601038 | NS      | $2890992.78   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics, Inc.                  | Iovance Biotherapeutics, Inc.                         | CUSIP: 462260100<br>LEI: 549300220Z2GHH33XL82 | Long             | EC               | CORP              | US        |   1186648 | NS      | $7582680.72   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics, Inc.                     | Sangamo Therapeutics, Inc.                            | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |   1056070 | NS      | $3316059.80   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Biomea Fusion, Inc.                            | Biomea Fusion, Inc.                                   | CUSIP: 09077A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    206555 | NS      | $1741258.65   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Annexon, Inc.                                  | Annexon, Inc.                                         | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    292603 | NS      | $1512757.51   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Syndax Pharmaceuticals, Inc.                   | Syndax Pharmaceuticals, Inc.                          | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |    424256 | NS      | $10797315.20  | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Karyopharm Therapeutics, Inc.                  | Karyopharm Therapeutics, Inc.                         | CUSIP: 48576U106<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |    605961 | NS      | $2060267.40   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Alnylam Pharmaceuticals, Inc.                  | Alnylam Pharmaceuticals, Inc.                         | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |   1021992 | NS      | $242876398.80 | 2.78%             |  |  |  | No            |                  1 | On Loan: —       |
| Vaxcyte, Inc.                                  | Vaxcyte, Inc.                                         | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |    490367 | NS      | $23513097.65  | 0.27%             |  |  |  | No            |                  1 | On Loan: —       |
| Keros Therapeutics, Inc.                       | Keros Therapeutics, Inc.                              | CUSIP: 492327101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    148110 | NS      | $7112242.20   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                            | Ascendis Pharma A/S                                   | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |    348003 | NS      | $42501606.39  | 0.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Novavax, Inc.                                  | Novavax, Inc.                                         | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |    655128 | NS      | $6734715.84   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Beam Therapeutics, Inc.                        | Beam Therapeutics, Inc.                               | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    482588 | NS      | $18874016.68  | 0.22%             |  |  |  | No            |                  1 | On Loan: —       |
| N/A                                            | Russell 2000 E-Mini Index                             | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |        36 | NC      | $-139095.64   | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals, Inc.                    | Agios Pharmaceuticals, Inc.                           | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |    440685 | NS      | $12374434.80  | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Verona Pharma plc                              | Verona Pharma plc                                     | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |    317562 | NS      | $8297895.06   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Axsome Therapeutics, Inc.                      | Axsome Therapeutics, Inc.                             | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |    291406 | NS      | $22476144.78  | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| 2seventy bio, Inc.                             | 2seventy bio, Inc.                                    | CUSIP: 901384107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    284922 | NS      | $2669719.14   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ALX Oncology Holdings, Inc.                    | ALX Oncology Holdings, Inc.                           | CUSIP: 00166B105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146081 | NS      | $1646332.87   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Humacyte, Inc.                                 | Humacyte, Inc.                                        | CUSIP: 44486Q103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    440258 | NS      | $928944.38    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| ADMA Biologics, Inc.                           | ADMA Biologics, Inc.                                  | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1572501 | NS      | $6101303.88   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Imago Biosciences, Inc.                        | Imago Biosciences, Inc.                               | CUSIP: 45250K107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    167757 | NS      | $6030864.15   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Cymabay Therapeutics, Inc.                     | Cymabay Therapeutics, Inc.                            | CUSIP: 23257D103<br>LEI: 549300YT9GNL852E7F84 | Long             | EC               | CORP              | US        |    677437 | NS      | $4247529.99   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Graphite Bio, Inc.                             | Graphite Bio, Inc.                                    | CUSIP: 38870X104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    223960 | NS      | $743547.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Crinetics Pharmaceuticals, Inc.                | Crinetics Pharmaceuticals, Inc.                       | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |    362512 | NS      | $6633969.60   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Repare Therapeutics, Inc.                      | Repare Therapeutics, Inc.                             | CUSIP: 760273102<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    257454 | NS      | $3787148.34   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Alector, Inc.                                  | Alector, Inc.                                         | CUSIP: 014442107<br>LEI: 549300Z8RQOIY1JMHC25 | Long             | EC               | CORP              | US        |    507618 | NS      | $4685314.14   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| AnaptysBio, Inc.                               | AnaptysBio, Inc.                                      | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |    218883 | NS      | $6783184.17   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcus Biosciences, Inc.                        | Arcus Biosciences, Inc.                               | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    372067 | NS      | $7694345.56   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Arvinas, Inc.                                  | Arvinas, Inc.                                         | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    384142 | NS      | $13141497.82  | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Kezar Life Sciences, Inc.                      | Kezar Life Sciences, Inc.                             | CUSIP: 49372L100<br>LEI: 549300EV1V8GXBV18004 | Long             | EC               | CORP              | US        |    483059 | NS      | $3400735.36   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Ginkgo Bioworks Holdings, Inc.                 | Ginkgo Bioworks Holdings, Inc.                        | CUSIP: 37611X100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   7894217 | NS      | $13341226.73  | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Geron Corp.                                    | Geron Corp.                                           | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |   2836434 | NS      | $6864170.28   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Vanda Pharmaceuticals, Inc.                    | Vanda Pharmaceuticals, Inc.                           | CUSIP: 921659108<br>LEI: 529900AY8VOOQBKJ0O70 | Long             | EC               | CORP              | US        |    455829 | NS      | $3368576.31   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Marinus Pharmaceuticals, Inc.                  | Marinus Pharmaceuticals, Inc.                         | CUSIP: 56854Q200<br>LEI: 549300NCT4OJF7JV1084 | Long             | EC               | CORP              | US        |    347974 | NS      | $1384936.52   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| NanoString Technologies, Inc.                  | NanoString Technologies, Inc.                         | CUSIP: 63009R109<br>LEI: 549300G4CK0Y3WRDMY89 | Long             | EC               | CORP              | US        |    387327 | NS      | $3086996.19   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Autolus Therapeutics plc                       | Autolus Therapeutics plc                              | CUSIP: 05280R100<br>LEI: 549300C0KZP8EYROLL02 | Long             | EC               | CORP              | GB        |    446273 | NS      | $847918.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| ACADIA Pharmaceuticals, Inc.                   | ACADIA Pharmaceuticals, Inc.                          | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |   1329438 | NS      | $21164652.96  | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| Lyell Immunopharma, Inc.                       | Lyell Immunopharma, Inc.                              | CUSIP: 55083R104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    671381 | NS      | $2329692.07   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Vertex Pharmaceuticals, Inc.                   | Vertex Pharmaceuticals, Inc.                          | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |   2141370 | NS      | $618384828.60 | 7.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences, Inc.                       | Cogent Biosciences, Inc.                              | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    496896 | NS      | $5744117.76   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Adicet Bio, Inc.                               | Adicet Bio, Inc.                                      | CUSIP: 007002108<br>LEI: 549300VRD2QO80WBOP18 | Long             | EC               | CORP              | US        |    236365 | NS      | $2113103.10   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| ARS Pharmaceuticals, Inc.                      | ARS Pharmaceuticals, Inc.                             | CUSIP: 82835W108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    152520 | NS      | $1300995.60   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Selecta Biosciences, Inc.                      | Selecta Biosciences, Inc.                             | CUSIP: 816212104<br>LEI: 529900NMN0LACZOL7C43 | Long             | EC               | CORP              | US        |    855718 | NS      | $966961.34    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Actinium Pharmaceuticals, Inc.                 | Actinium Pharmaceuticals, Inc.                        | CUSIP: 00507W206<br>LEI: 549300LCY1NZSXCQDT45 | Long             | EC               | CORP              | US        |    208008 | NS      | $2215285.20   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Evelo Biosciences, Inc.                        | Evelo Biosciences, Inc.                               | CUSIP: 299734103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    446490 | NS      | $718848.90    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| REGENXBIO, Inc.                                | REGENXBIO, Inc.                                       | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |    326565 | NS      | $7406494.20   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| BioCryst Pharmaceuticals, Inc.                 | BioCryst Pharmaceuticals, Inc.                        | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |   1535885 | NS      | $17631959.80  | 0.20%             |  |  |  | No            |                  1 | On Loan: —       |
| Revance Therapeutics, Inc.                     | Revance Therapeutics, Inc.                            | CUSIP: 761330109<br>LEI: 549300N33TFDZHS81H11 | Long             | EC               | CORP              | US        |    643293 | NS      | $11875188.78  | 0.14%             |  |  |  | No            |                  1 | On Loan: —       |
| Zentalis Pharmaceuticals, Inc.                 | Zentalis Pharmaceuticals, Inc.                        | CUSIP: 98943L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    420057 | NS      | $8459947.98   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Legend Biotech Corp.                           | Legend Biotech Corp.                                  | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |   1026326 | NS      | $51234193.92  | 0.59%             |  |  |  | No            |                  1 | On Loan: —       |
| Arrowhead Pharmaceuticals, Inc.                | Arrowhead Pharmaceuticals, Inc.                       | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |    864455 | NS      | $35062294.80  | 0.40%             |  |  |  | No            |                  1 | On Loan: —       |
| Stevanato Group SpA                            | Stevanato Group SpA                                   | CUSIP: N/A<br>LEI: 81560033F7E1CD477507       | Long             | EC               | CORP              | IT        |    276988 | NS      | $4977474.36   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Avidity Biosciences, Inc.                      | Avidity Biosciences, Inc.                             | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    411372 | NS      | $9128344.68   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Zymeworks, Inc.                                | Zymeworks, Inc.                                       | CUSIP: 98985Y108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    484915 | NS      | $3811431.90   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Immunovant, Inc.                               | Immunovant, Inc.                                      | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    433443 | NS      | $7693613.25   | 0.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Karuna Therapeutics, Inc.                      | Karuna Therapeutics, Inc.                             | CUSIP: 48576A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    230003 | NS      | $45195589.50  | 0.52%             |  |  |  | No            |                  1 | On Loan: —       |
| Vir Biotechnology, Inc.                        | Vir Biotechnology, Inc.                               | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    668975 | NS      | $16931757.25  | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics, Inc.                       | Akero Therapeutics, Inc.                              | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |    299096 | NS      | $16390460.80  | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Maravai LifeSciences Holdings, Inc.            | Maravai LifeSciences Holdings, Inc., Class A          | CUSIP: 56600D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    909020 | NS      | $13008076.20  | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics, Inc.                    | Intellia Therapeutics, Inc.                           | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    612602 | NS      | $21373683.78  | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| ImmunoGen, Inc.                                | ImmunoGen, Inc.                                       | CUSIP: 45253H101<br>LEI: 54930084U0R1OP766Y02 | Long             | EC               | CORP              | US        |   1836447 | NS      | $9108777.12   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| I-Mab                                          | I-Mab                                                 | CUSIP: 44975P103<br>LEI: 549300L1A5T19703RR64 | Long             | EC               | CORP              | KY        |    515476 | NS      | $2154689.68   | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Acumen Pharmaceuticals, Inc.                   | Acumen Pharmaceuticals, Inc.                          | CUSIP: 00509G209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    211266 | NS      | $1140836.40   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Mersana Therapeutics, Inc.                     | Mersana Therapeutics, Inc.                            | CUSIP: 59045L106<br>LEI: 529900VWD5VDZ7PVOS22 | Long             | EC               | CORP              | US        |    658313 | NS      | $3857714.18   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| BioAtla, Inc.                                  | BioAtla, Inc.                                         | CUSIP: 09077B104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    293685 | NS      | $2422901.25   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Precigen, Inc.                                 | Precigen, Inc.                                        | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |    824754 | NS      | $1253626.08   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Aurinia Pharmaceuticals, Inc.                  | Aurinia Pharmaceuticals, Inc.                         | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |   1083406 | NS      | $4680313.92   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III                            | BlackRock Cash Funds: Institutional, SL Agency Shares | CUSIP: 066922519<br>LEI: 549300JDHS1T46VWOG19 | Long             | STIV             | RF                | US        | 808796494 | NS      | $809039132.83 | 9.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp.                     | Scholar Rock Holding Corp.                            | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |    322074 | NS      | $2914769.70   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Altimmune, Inc.                                | Altimmune, Inc.                                       | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |    401229 | NS      | $6600217.05   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| IQVIA Holdings, Inc.                           | IQVIA Holdings, Inc.                                  | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |   1542755 | NS      | $316095071.95 | 3.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptimmune Therapeutics plc                   | Adaptimmune Therapeutics plc                          | CUSIP: 00653A107<br>LEI: 549300UUNWK8TRT5EW12 | Long             | EC               | CORP              | GB        |    882285 | NS      | $1288136.10   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Provention Bio, Inc.                           | Provention Bio, Inc.                                  | CUSIP: 74374N102<br>LEI: 5493003LM26XAVJKLD34 | Long             | EC               | CORP              | US        |    665894 | NS      | $7038499.58   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| Protagonist Therapeutics, Inc.                 | Protagonist Therapeutics, Inc.                        | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    367492 | NS      | $4009337.72   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| PMV Pharmaceuticals, Inc.                      | PMV Pharmaceuticals, Inc.                             | CUSIP: 69353Y103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    262682 | NS      | $2285333.40   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| ImmunityBio, Inc.                              | ImmunityBio, Inc.                                     | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |    693874 | NS      | $3517941.18   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| N/A                                            | XAV Health Care Index                                 | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |        67 | NC      | $-309170.29   | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Alaunos Therapeutics, Inc.                     | Alaunos Therapeutics, Inc.                            | CUSIP: 98973P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1582426 | NS      | $1027152.72   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Travere Therapeutics, Inc.                     | Travere Therapeutics, Inc.                            | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    513950 | NS      | $10808368.50  | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Bridgebio Pharma, Inc.                         | Bridgebio Pharma, Inc.                                | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |    888736 | NS      | $6772168.32   | 0.08%             |  |  |  | No            |                  1 | On Loan: —       |
| BeiGene Ltd.                                   | BeiGene Ltd.                                          | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | KY        |    583727 | NS      | $128384916.38 | 1.47%             |  |  |  | No            |                  1 | On Loan: —       |
| G1 Therapeutics, Inc.                          | G1 Therapeutics, Inc.                                 | CUSIP: 3621LQ109<br>LEI: 529900TC35UPZQYRKW13 | Long             | EC               | CORP              | US        |    346095 | NS      | $1879295.85   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| RAPT Therapeutics, Inc.                        | RAPT Therapeutics, Inc.                               | CUSIP: 75382E109<br>LEI: 549300MB473BIU78ES48 | Long             | EC               | CORP              | US        |    210957 | NS      | $4176948.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Adaptive Biotechnologies Corp.                 | Adaptive Biotechnologies Corp.                        | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |   1168405 | NS      | $8926614.20   | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| Rocket Pharmaceuticals, Inc.                   | Rocket Pharmaceuticals, Inc.                          | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |    582416 | NS      | $11397881.12  | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcellx, Inc.                                  | Arcellx, Inc.                                         | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    186157 | NS      | $5767143.86   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen, Inc.                                    | Amgen, Inc.                                           | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |   2532939 | NS      | $665251098.96 | 7.61%             |  |  |  | No            |                  1 | On Loan: No      |
| C4 Therapeutics, Inc.                          | C4 Therapeutics, Inc.                                 | CUSIP: 12529R107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    342148 | NS      | $2018673.20   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Cara Therapeutics, Inc.                        | Cara Therapeutics, Inc.                               | CUSIP: 140755109<br>LEI: 549300COVOY41P0GZ881 | Long             | EC               | CORP              | US        |    352812 | NS      | $3789200.88   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Affimed NV                                     | Affimed NV                                            | CUSIP: N/A<br>LEI: 5493004V4FSXT1D04610       | Long             | EC               | CORP              | NL        |   1048104 | NS      | $1299648.96   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Halozyme Therapeutics, Inc.                    | Halozyme Therapeutics, Inc.                           | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |   1121477 | NS      | $63812041.30  | 0.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Invitae Corp.                                  | Invitae Corp.                                         | CUSIP: 46185L103<br>LEI: 549300MYI59DZW1WIX92 | Long             | EC               | CORP              | US        |   1988366 | NS      | $3698360.76   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Morphic Holding, Inc.                          | Morphic Holding, Inc.                                 | CUSIP: 61775R105<br>LEI: 549300RWWOUFLHTY1224 | Long             | EC               | CORP              | US        |    244535 | NS      | $6541311.25   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| IGM Biosciences, Inc.                          | IGM Biosciences, Inc.                                 | CUSIP: 449585108<br>LEI: 5493008XCQES2N0VY969 | Long             | EC               | CORP              | US        |    144946 | NS      | $2465531.46   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Allakos, Inc.                                  | Allakos, Inc.                                         | CUSIP: 01671P100<br>LEI: 549300S6ZD1W6BPMDY37 | Long             | EC               | CORP              | US        |    393655 | NS      | $3314575.10   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Krystal Biotech, Inc.                          | Krystal Biotech, Inc.                                 | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |    172264 | NS      | $13646754.08  | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Prelude Therapeutics, Inc.                     | Prelude Therapeutics, Inc.                            | CUSIP: 74065P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    137698 | NS      | $831695.92    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| BlackRock Funds III                            | BlackRock Cash Funds: Treasury, SL Agency Shares      | CUSIP: 066922477<br>LEI: 5493005PQV5UQG4OSI49 | Long             | STIV             | RF                | US        |  14324577 | NS      | $14324576.58  | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics, Inc.                  | Monte Rosa Therapeutics, Inc.                         | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    249908 | NS      | $1901799.88   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Relay Therapeutics, Inc.                       | Relay Therapeutics, Inc.                              | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    707682 | NS      | $10572769.08  | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Fulcrum Therapeutics, Inc.                     | Fulcrum Therapeutics, Inc.                            | CUSIP: 359616109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    333692 | NS      | $2429277.76   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Regeneron Pharmaceuticals, Inc.                | Regeneron Pharmaceuticals, Inc.                       | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |    857605 | NS      | $618753431.45 | 7.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Gracell Biotechnologies, Inc.                  | Gracell Biotechnologies, Inc.                         | CUSIP: 38406L103<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |    365980 | NS      | $841754.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Contra Ligand Pharmace                         | Contra Ligand Pharmace                                | CUSIP: 532CNT029<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     46839 | NS      | $0.47         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Myovant Sciences Ltd.                          | Myovant Sciences Ltd.                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | BM        |    364158 | NS      | $9817699.68   | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| CRISPR Therapeutics AG                         | CRISPR Therapeutics AG                                | CUSIP: N/A<br>LEI: 506700O6IRRIQLT3W370       | Long             | EC               | CORP              | CH        |    629444 | NS      | $25586898.60  | 0.29%             |  |  |  | No            |                  1 | On Loan: —       |
| Gilead Sciences, Inc.                          | Gilead Sciences, Inc.                                 | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |   8259521 | NS      | $709079877.85 | 8.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology, Inc.                       | Sana Biotechnology, Inc.                              | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    684671 | NS      | $2704450.45   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| iTeos Therapeutics, Inc.                       | iTeos Therapeutics, Inc.                              | CUSIP: 46565G104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    241530 | NS      | $4717080.90   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| PepGen, Inc.                                   | PepGen, Inc.                                          | CUSIP: 713317105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    159445 | NS      | $2131779.65   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Seagen, Inc.                                   | Seagen, Inc.                                          | CUSIP: 81181C104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1529769 | NS      | $196590614.19 | 2.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Apellis Pharmaceuticals, Inc.                  | Apellis Pharmaceuticals, Inc.                         | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |    770348 | NS      | $39834695.08  | 0.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Incyte Corp.                                   | Incyte Corp.                                          | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |   1846069 | NS      | $148276262.08 | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Nautilus Biotechnology, Inc.                   | Nautilus Biotechnology, Inc.                          | CUSIP: 63909J108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    354138 | NS      | $637448.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Gossamer Bio, Inc.                             | Gossamer Bio, Inc.                                    | CUSIP: 38341P102<br>LEI: 549300ZOC0N2W6PSFR58 | Long             | EC               | CORP              | US        |    622031 | NS      | $1349807.27   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Grifols SA                                     | Grifols SA                                            | CUSIP: 398438408<br>LEI: 959800HSSNXWRKBK4N60 | Long             | EC               | CORP              | ES        |   1619976 | NS      | $13769796.00  | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Denali Therapeutics, Inc.                      | Denali Therapeutics, Inc.                             | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |    970422 | NS      | $26987435.82  | 0.31%             |  |  |  | No            |                  1 | On Loan: —       |
| GreenLight Biosciences Holdings PBC            | GreenLight Biosciences Holdings PBC                   | CUSIP: 39536G105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    516888 | NS      | $609927.84    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| AbCellera Biologics, Inc.                      | AbCellera Biologics, Inc.                             | CUSIP: 00288U106<br>LEI: 9845000861BC95FF9F73 | Long             | EC               | CORP              | CA        |   1580507 | NS      | $16010535.91  | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| Immunocore Holdings plc                        | Immunocore Holdings plc                               | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |    273916 | NS      | $15632386.12  | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| CureVac NV                                     | CureVac NV                                            | CUSIP: N/A<br>LEI: 724500BUT8GAG9LMYN56       | Long             | EC               | CORP              | NL        |    599466 | NS      | $3614779.98   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| BioNTech SE                                    | BioNTech SE                                           | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |   1502062 | NS      | $225639753.64 | 2.58%             |  |  |  | No            |                  1 | On Loan: —       |
| NGM Biopharmaceuticals, Inc.                   | NGM Biopharmaceuticals, Inc.                          | CUSIP: 62921N105<br>LEI: 5493008V5DSDZIGQOP17 | Long             | EC               | CORP              | US        |    314007 | NS      | $1576315.14   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Foghorn Therapeutics, Inc.                     | Foghorn Therapeutics, Inc.                            | CUSIP: 344174107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146077 | NS      | $931971.26    | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Arbutus Biopharma Corp.                        | Arbutus Biopharma Corp.                               | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |   1145156 | NS      | $2668213.48   | 0.03%             |  |  |  | No            |                  1 | On Loan: —       |
| Chinook Therapeutics, Inc.                     | Chinook Therapeutics, Inc.                            | CUSIP: 16961L106<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |    385524 | NS      | $10100728.80  | 0.12%             |  |  |  | No            |                  1 | On Loan: —       |
| Nkarta, Inc.                                   | Nkarta, Inc.                                          | CUSIP: 65487U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    306672 | NS      | $1836965.28   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Voyager Therapeutics, Inc.                     | Voyager Therapeutics, Inc.                            | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |    229955 | NS      | $1402725.50   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Erasca, Inc.                                   | Erasca, Inc.                                          | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    555384 | NS      | $2393705.04   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Emergent BioSolutions, Inc.                    | Emergent BioSolutions, Inc.                           | CUSIP: 29089Q105<br>LEI: 549300YW6TUOX8BE5103 | Long             | EC               | CORP              | US        |    340975 | NS      | $4026914.75   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Aclaris Therapeutics, Inc.                     | Aclaris Therapeutics, Inc.                            | CUSIP: 00461U105<br>LEI: 5493000B2LQ9QTW1DF52 | Long             | EC               | CORP              | US        |    429407 | NS      | $6763160.25   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Inovio Pharmaceuticals, Inc.                   | Inovio Pharmaceuticals, Inc.                          | CUSIP: 45773H201<br>LEI: 529900B9W875XDZXTM97 | Long             | EC               | CORP              | US        |   2060276 | NS      | $3214030.56   | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Achillion Pharmaceuticals, Inc.                | Achillion Pharmaceuticals, Inc., CVR                  | CUSIP: 004CVR031<br>LEI: 529900LZPJ796VSWZM38 | Long             |  | CORP              | US        |      4112 | NS      | $1891.52      | 0.00%             |  |  |  | No            |                  3 | On Loan: —       |
| IVERIC bio, Inc.                               | IVERIC bio, Inc.                                      | CUSIP: 46583P102<br>LEI: 549300GZXI59U71XPM70 | Long             | EC               | CORP              | US        |    973915 | NS      | $20851520.15  | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| Compass Pathways plc                           | Compass Pathways plc                                  | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |    271190 | NS      | $2177655.70   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Instil Bio, Inc.                               | Instil Bio, Inc.                                      | CUSIP: 45783C101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    501314 | NS      | $315827.82    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Oyster Point Pharma, Inc.                      | Oyster Point Pharma, Inc.                             | CUSIP: 69242L106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    106476 | NS      | $1189336.92   | 0.01%             |  |  |  | No            |                  1 | On Loan: —       |
| Concert Pharmaceuticals, Inc.                  | Concert Pharmaceuticals, Inc.                         | CUSIP: 206022105<br>LEI: 529900PYI5BSGQNATP82 | Long             | EC               | CORP              | US        |    379504 | NS      | $2216303.36   | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna, Inc.                                  | Moderna, Inc.                                         | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |   2768454 | NS      | $497269707.48 | 5.69%             |  |  |  | No            |                  1 | On Loan: —       |
| Alkermes plc                                   | Alkermes plc                                          | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | IE        |   1356695 | NS      | $35450440.35  | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte, Inc.                                 | Veracyte, Inc.                                        | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |    593223 | NS      | $14077181.79  | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Gritstone bio, Inc.                            | Gritstone bio, Inc.                                   | CUSIP: 39868T105<br>LEI: 5493003TER6KY3MUVY84 | Long             | EC               | CORP              | US        |    590191 | NS      | $2036158.95   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Anavex Life Sciences Corp.                     | Anavex Life Sciences Corp.                            | CUSIP: 032797300<br>LEI: 549300K1I5L8COCQ8W36 | Long             | EC               | CORP              | US        |    633071 | NS      | $5862237.46   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Akouos, Inc.                                   | Akouos, Inc., CVR                                     | CUSIP: 009CVR036<br>LEI: N/A                  | Long             |  | CORP              | US        |    157087 | NS      | $124098.73    | 0.00%             |  |  |  | No            |                  2 | On Loan: —       |
| Terns Pharmaceuticals, Inc.                    | Terns Pharmaceuticals, Inc.                           | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |    133013 | NS      | $1354072.34   | 0.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Verve Therapeutics, Inc.                       | Verve Therapeutics, Inc.                              | CUSIP: 92539P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    316749 | NS      | $6129093.15   | 0.07%             |  |  |  | No            |                  1 | On Loan: —       |
| EQRx, Inc.                                     | EQRx, Inc.                                            | CUSIP: 26886C107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1720777 | NS      | $4233111.42   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2022-12-31

**Name of Applicant:** iShares Trust

**Signature:** Ann Frechette

**Name of Signer:** Ann Frechette

**Title:** Assistant Treasurer